Subhankar P. Mandal

Novel glitazones as PPARγ agonists: molecular design, synthesis, glucose uptake activity and 3D QSAR studies

Subhankar P. Mandal, Aakriti Garg, Ashish Wadhwani et al. · Chemistry Central Journal · 2018 · 44 citations · Full text

α‐Glucosidase, α‐Amylase Inhibition, Kinetics and Docking Studies of Novel (2‐Chloro‐6‐(trifluoromethyl)benzyloxy)arylidene) Based Rhodanine and Rhodanine Acetic Acid Derivatives

Vasantha Kumar, Ramith Ramu, Prithvi S. Shirahatti et al. · ChemistrySelect · 2021 · 44 citations

Pharmaceutical Science, Bioorganic Chemistry, Organic Chemistry +18

Novel rhodanines with anticancer activity: design, synthesis and CoMSIA study

Subhankar P. Mandal, Mithuna Mithuna, Aakriti Garg et al. · RSC Advances · 2016 · 38 citations

Novel Rhodanines, Medicinal Chemistry, Health Sciences +14

Rational Design, Synthesis, and In Vitro Neuroprotective Evaluation of Novel Glitazones for PGC-1α Activation via PPAR-γ: a New Therapeutic Strategy for Neurodegenerative Disorders

Antony Justin, Subhankar P. Mandal, S. Yuvaraj et al. · Neurotoxicity Research · 2019 · 28 citations

Neurodegenerative Diseases, Novel Glitazones, Rational Design +9

Novel Imidazole Phenoxyacetic Acids as Inhibitors of USP30 for Neuroprotection Implication via the Ubiquitin-Rho-110 Fluorometric Assay: Design, Synthesis, and In Silico and Biochemical Assays

Subhankar P. Mandal, B. R. Prashantha Kumar, Md Tanjim Alam et al. · ACS Chemical Neuroscience · 2022 · 20 citations